1MELD Score — 90-Day Mortality & Waitlist Triage
| MELD Score Range | Estimated 3-Month Mortality | UNOS Allocation Status & Triage |
|---|---|---|
| < 10 | ~1.9% | Low severity; managed conservatively in outpatient hepatology clinics. |
| 10 – 19 | ~6.0% | Moderate risk; MELD ≥15 is the standard threshold for transplant listing evaluation. |
| 20 – 29 | ~19.6% | High mortality; active inpatient monitoring and accelerated listing evaluation. |
| 30 – 39 | ~52.6% | Very high risk; urgent waitlist priority and critical care stabilization. |
| ≥ 40 | >71.3% (up to 90%) | Critical decompensation; immediate highest allocation priority (Status 1A candidate). |
2Why Serum Sodium Matters (MELD-Na)
In advanced cirrhosis, severe splanchnic arterial vasodilatation triggers intense compensatory activation of the renin-angiotensin-aldosterone system (RAAS), the sympathetic nervous system, and non-osmotic hypersecretion of vasopressin (ADH). This causes persistent free water retention, presenting biochemically as hypervolemic hyponatremia.
Extensive multicenter studies proved that cirrhotics with identical MELD scores but lower serum sodium suffer significantly higher 90-day waitlist mortality. In January 2016, UNOS formally adopted MELD-Na as the national standard for deceased donor liver allocation. A cirrhotic with a base MELD of 21 and a serum sodium of 126 mmol/L receives a MELD-Na score of 27, correctly advancing their allocation priority.
3MELD 3.0 & Sex Equity in Transplantation
Introduced in 2021 by Kim et al., MELD 3.0 was developed to address structural disparities: female liver transplant candidates historically experienced higher waitlist mortality because their lower baseline muscle mass produced lower serum creatinine values for equivalent renal impairment. MELD 3.0 incorporates serum albumin, interaction terms, and an explicit female-sex correction coefficient (+1.33 points), improving predictive concordance.
4Clinical Applications Beyond Transplantation
- Perioperative Surgical Risk in Cirrhosis: MELD is superior to Child-Pugh in predicting 30-day postoperative surgical mortality. MELD <10 carries ~4% mortality; MELD 10–15 carries ~9%; MELD >15 carries >25%. Elective surgeries are contraindicated when MELD >20.
- Severe Alcoholic Hepatitis: Evaluated in tandem with the Maddrey Discriminant Function (MDF). A MELD score >20 on admission indicates severe alcoholic hepatitis with high 28-day mortality, supporting corticosteroid therapy if active infection is ruled out.
- Acute Variceal Bleeding: An admission MELD ≥19 independently predicts treatment failure and 6-week mortality following acute variceal hemorrhage, identifying candidates who benefit from early preemptive TIPS within 72 hours.